New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 130345-50-5, name is Quinoxaline-6-carbaldehyde, introducing its new discovery. Safety of Quinoxaline-6-carbaldehyde
The present invention relates to O-GlcNAc hydrolase (OGA) inhibitors. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which inhibition of OGA is beneficial, such as tauopathies, in particular Alzheimer’s disease or progressive supranuclear palsy; and neurodegenerative diseases accompanied by a tau pathology, in particular amyotrophic lateral sclerosis or frontotemporal lobe dementia caused by C9ORF72 mutations.
Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. Safety of Quinoxaline-6-carbaldehyde, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 130345-50-5, in my other articles.
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N204 | ChemSpider